The first vaccines against respiratory syncytial virus (VRS) have been available since 2023. What is RSV? Who are the people at risk? What is the effectiveness of the vaccines and medicines available? If they represent an important step forward for public health in the fight against this virus, improvements are still needed.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The first vaccines against respiratory syncytial virus (VRS) have been available since 2023. What is RSV? Who are the people at risk? What is the effectiveness of the vaccines and medicines available? If they represent an important step forward for public health in the fight against this virus, improvements are still needed.